[go: up one dir, main page]

BR9508323A - Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas - Google Patents

Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas

Info

Publication number
BR9508323A
BR9508323A BR9508323A BR9508323A BR9508323A BR 9508323 A BR9508323 A BR 9508323A BR 9508323 A BR9508323 A BR 9508323A BR 9508323 A BR9508323 A BR 9508323A BR 9508323 A BR9508323 A BR 9508323A
Authority
BR
Brazil
Prior art keywords
sulfate
heparin
chitosan
wound healing
tissues
Prior art date
Application number
BR9508323A
Other languages
English (en)
Inventor
Hans-Arne Hansson
Gunilla Johansson-Ruden
Olle Larm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9508323A publication Critical patent/BR9508323A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Amplifiers (AREA)
  • Optical Communication System (AREA)
  • Glass Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9508323A 1994-07-19 1995-07-13 Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas BR9508323A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402529A SE9402529D0 (sv) 1994-07-19 1994-07-19 Anti-adherensmedel
PCT/SE1995/000856 WO1996002258A1 (en) 1994-07-19 1995-07-13 Anti-adhesion agent

Publications (1)

Publication Number Publication Date
BR9508323A true BR9508323A (pt) 1998-01-06

Family

ID=20394769

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508323A BR9508323A (pt) 1994-07-19 1995-07-13 Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas

Country Status (21)

Country Link
EP (1) EP0772446B1 (pt)
JP (1) JP4033485B2 (pt)
KR (1) KR100395723B1 (pt)
CN (1) CN1157569A (pt)
AT (1) ATE226439T1 (pt)
AU (1) AU708758B2 (pt)
BR (1) BR9508323A (pt)
CA (1) CA2194476C (pt)
CZ (1) CZ287692B6 (pt)
DE (1) DE69528654T2 (pt)
DK (1) DK0772446T3 (pt)
ES (1) ES2180649T3 (pt)
FI (1) FI970201A0 (pt)
HU (1) HUT77606A (pt)
IS (1) IS1794B (pt)
MX (1) MX9700442A (pt)
NO (1) NO310222B1 (pt)
NZ (1) NZ290218A (pt)
RU (1) RU2155592C2 (pt)
SE (1) SE9402529D0 (pt)
WO (1) WO1996002258A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402531L (sv) * 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6645947B1 (en) * 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
SE523243C3 (sv) * 1999-09-28 2004-05-26 Medicarb Ab Antimikrobiellt preparat för behandling och profylax
ES2169681B1 (es) * 2000-08-10 2003-10-01 Osfarma S L Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
KR20020066024A (ko) * 2001-02-08 2002-08-14 굿젠 주식회사 수용성 키토산과 헤파린으로 이루어진 상처 치유 촉진연고 조성물과 필름 및 제품
WO2002083104A1 (en) * 2001-04-12 2002-10-24 Medicarb Ab An effervescent solid composition of matter
SE522529C2 (sv) 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US7642395B2 (en) 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
EP2126106B1 (en) * 2007-02-23 2017-09-06 Sk Chemicals Co., Ltd. Process for producing and purifying factor viii and its derivatives
JP5489999B2 (ja) * 2007-08-28 2014-05-14 アデレード リサーチ アンド イノベーション ピーティーワイ リミテッド 外科用ハイドロゲル
RU2379763C1 (ru) * 2008-06-23 2010-01-20 Вячеслав Александрович Липатов Способ моделирования внутриматочной адгезии
PL235185B1 (pl) 2008-07-02 2020-06-01 Univ Jagiellonski Polimer chitozanowy do zastosowania do usuwania heparyny
RU2011152518A (ru) 2009-06-10 2013-07-20 Экстера Аб Применение композиции для лечения мукозита
CN105142399B (zh) 2013-03-14 2018-06-12 金珂生物医疗公司 生物相容的和生物可吸收的衍生的壳聚糖组合物
CN103341217B (zh) * 2013-06-13 2015-05-06 上海大学 一种用于防止手术后组织粘连的薄膜的制备方法
KR101664444B1 (ko) 2013-12-13 2016-10-12 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 생분해성 의료용 접착제 또는 실란트 조성물
CN106362221B (zh) * 2016-09-30 2019-06-21 天津大学 一种具有抑菌促愈合功能的防粘连材料及其制备方法
KR200490615Y1 (ko) 2016-10-20 2020-01-13 주식회사 인트로컴퍼니 사용자 맞춤형 캘린더
WO2019211483A1 (en) * 2018-05-04 2019-11-07 Bonoss Medical Aktiebolag A composition for reduction of scar formation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法

Also Published As

Publication number Publication date
AU3089495A (en) 1996-02-16
ES2180649T3 (es) 2003-02-16
CZ13997A3 (en) 1997-07-16
IS1794B (is) 2001-12-12
CA2194476A1 (en) 1996-02-01
EP0772446A1 (en) 1997-05-14
MX9700442A (es) 1997-04-30
ATE226439T1 (de) 2002-11-15
CZ287692B6 (en) 2001-01-17
DE69528654T2 (de) 2003-03-13
NO310222B1 (no) 2001-06-11
FI970201A7 (fi) 1997-01-17
IS4410A (is) 1997-01-06
NO970214D0 (no) 1997-01-17
NO970214L (no) 1997-01-17
CA2194476C (en) 2009-09-22
WO1996002258A1 (en) 1996-02-01
JPH10502663A (ja) 1998-03-10
DE69528654D1 (de) 2002-11-28
EP0772446B1 (en) 2002-10-23
NZ290218A (en) 1999-02-25
AU708758B2 (en) 1999-08-12
FI970201L (fi) 1997-01-17
SE9402529D0 (sv) 1994-07-19
HU9700161D0 (en) 1997-03-28
KR100395723B1 (ko) 2004-02-18
CN1157569A (zh) 1997-08-20
KR970704458A (ko) 1997-09-06
DK0772446T3 (da) 2002-11-25
HUT77606A (hu) 1998-06-29
RU2155592C2 (ru) 2000-09-10
JP4033485B2 (ja) 2008-01-16
FI970201A0 (fi) 1997-01-17

Similar Documents

Publication Publication Date Title
BR9508323A (pt) Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas
CA2194976A1 (en) Wound healing agent
FI954654A0 (fi) Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen
BR9508322A (pt) Uso de quitosan e de um polissacarídeo imobilizado no mesmo processo para estimular e/ou acelerar regeneração de tecido rígido e implante destinado para integração em tecido rígido
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
AU5622198A (en) Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
CA2266811A1 (en) Method and composition for wound treatment
BR9406424A (pt) Processo para reduzir a tendencia a fibrilação de fibra de celulose fiada com solvente e fibra de celulose fiada com solvente com uma tendencia reduzida à fibrilação
ES2101499T3 (es) Fibras.
BR9906477A (pt) Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado
BR0209688A (pt) Método e composição para reduzir fixação bacteriana em biomateriais
BR9507414A (pt) Composição aquosa de revestimento para fibras de vidro pluralidade de fibras de vidro e composto de poliolefina reforçado com fibra de vidro
DE69610214D1 (de) Aktives lärmverminderungssystem für geschlossene raume,insbesondere flugzeugkabine
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
ATE285713T1 (de) Platte für orthopädischen fixateur
RU97102350A (ru) Анти-адгезионный агент
BR9913156A (pt) Composição e processo para condicionamento, clareamento e realce do cabelo
WO1996040743A3 (en) Inhibitors of factor xa
AU1724501A (en) Bioabsorbable, osteopromoting fixation plate
WO1997030714A3 (en) Topical pharmaceutical composition containing heparin
AU7348496A (en) Surgical extension arrangement for the extension and expansion of tissue
AU5448490A (en) Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
CA2184692A1 (en) Hypocholesterolemic, Antiatherosclerotic and Hypotriglyceridemic Mercaptoacetylamide Disulfide Derivatives

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/722 (2006.01), A61K 31/727 (2006.0